(239) 330-7495
conference@agemed.org
Contact
Course Log In
Membership
REGISTER HERE
Primary Menu
Conferences
Florida April 2025
General Information
Registration
Agenda
Faculty
Hotel & Travel Info
Planning Committee
Accreditation
Utah November 2025
General Information
Hotel & Travel Info
Planning Committee
General
Conferences Overview
Conference Archives
Planning Committee
Call for Presenters
Exhibitor Info & Directory
Become a Sponsor / Exhibitor
Certification
Age Management Medicine
Brochure
Application
Faculty
Planning Committee
Accreditation
Certification Login
Online Education
Online Education Portal
Webinars
Login/My Account
My Cart
My Courses
Membership
e-Journal
Overview
Current Issue
Archives
Subscribe
Advertise
Submit Articles
About
About AMMG
Membership
What is Age Management Medicine?
Mission Statement
Awards
Alan P. Mintz, M.D.
L. Stephen Coles, M.D., Ph.D.
Advisory Board
Age Management Medicine Glossary
Suggested Readings
Contact AMMG
Sponsors
AMMG Sponsors
Sponsors Products & Services
April 2025 Exhibitor & Sponsor Information
Become a Sponsor / Exhibitor
Sponsor Marketing Opportunities
0
Cart
No products in the cart.
Role of DEA and FDA in Use of CBD and THC
Home
CBD, THC and Cannabis Derived Therapies
Role of DEA and FDA in Use of CBD and THC
SKU:
e37e81688723
Categories:
CBD, THC and Cannabis Derived Therapies
,
Legal Issues & Practice Management Perspectives
.
Role of DEA and FDA in Use of CBD and THC
$
69.00
Role of DEA and FDA in Use of CBD and THC quantity
Add to cart
Prev
Next
If you’ve already purchased this course,
visit the course page
.
You may be interested in
How Cannabis Battles the So-Called Opiate Epidemic
$
59.00
Add to cart
CBD and THC as a Treatment for Neurological Disease
$
69.00
Add to cart
Alzheimer’s Disease/Dementia and Cannabinoids- Is it an Option?
$
69.00
Add to cart
Full Spectrum Cannabis: Benefits Beyond THC and CBD
$
59.00
Add to cart
